All industries
2087
results for
All industries
Filters
Refine your search
Solvent, co-solvent and chelating agent designed for
injectable formulations. Benefits:
- Helps to maintain low level of endotoxins and metallic impurities
- Compliant with USP and Ph. Eur
TDS
Excipient developed for pharmaceutical formulations. It is used as a chelating agent in solid and semi-solid dosage forms. Benefits:
- Complies with Ph. Eur.
TDS
Excipient developed for pharmaceutical applications. It functions as a chelating agent in solid and
semi-solid dosage forms.Benefits:
- Complies with USP and Ph. Eur.
TDS
Excipient designed for pharmaceutical formulations.Benefits:
- Complies with BP specifications
TDS
Excipient designed to be used in pharmaceutical applications.Benefits:
- Complies with Ph Eur specifications
TDS
Excipient designed for pharmaceutical applications. Benefits:
- Complies with Ph Eur
TDS
Excipient designed for pharmaceutical applications. Benefits:
- Freely soluble in water and practically insoluble in ethanol
- Complies with Ph Eur, BP and USP specifications
TDS
Excipient designed for use in pharmaceutical formulations. Benefits:
- Available in colorless crystals
- Very soluble in water, slightly soluble in ethanol (96%)
- Complies with USP and BP specifications
TDS
Excipient designed for pharmaceutical applications. Benefits:
- Meets with CDMF specifications
- DMF # 31178
- CDE # F20200000141
TDS
Excipient designed for pharmaceutical applications. Benefits:
- Complies with HP specifications
TDS
Excipient developed for pharmaceutical applications. It is
used as pH modifier and buffering agent in injectable formulations. Benefits:
- Complies with HP specifications
- Helps to maintain low level of endotoxins and metallic impurities
TDS
Buffering agent and pH modifier developed exclusively for use in injectable formulations.Benefits:
- DMF Filed - CDE # F20200000141
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Excipient developed for pharmaceutical applications. It is
used as a pH modifier and buffering agent in injectable formulations. Benefits:
- Complies with USP-NF specifications
- Helps to maintain a low level of endotoxins and metallic impurities
TDS
Chelating agent excipient developed for solid and semi-solid dosage forms.Benefits:
- Complies with USP specifications
TDS
Solvent developed for pharmaceutical applications. It is
suitable for oral solid dosage formulations.
Benefits:
- Highly pure
- ICH Q3D compliant
TDS
Concentrated pigment dispersion (PB 15:4) in
a polyether polyol suitable for coloring thermoplastic and thermosetting
polyurethane elastomers.Benefits:
- Pourable and pumpable
- Exhibits resistance to acids, alkalis & solvents
- Displays heat fastness
TDS
Actylis
Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries.
Safic-Alcan
Safic-Alcan is a French independent distributor of specialty chemicals headquartered in Paris La Défense (France). The Company develops and provides wide ranges of polymers, materials and additives for the rubber, coatings, adhesives, thermoplastics, polyurethane, lubricants, detergency, cosmetics, pharmaceuticals, and nutraceuticals industries. With a network of 35 offices strategically located in Europe, Turkey, Middle East, North America, Mexico, South America, China and South Africa, and 780 people worldwide, Safic-Alcan generated a turnover of 907 M€ in 2022.
